Market Insights: Options Trading Activity in Key Stocks
Among the components of the Russell 3000 index, today’s options trading activity highlights several key players. Abbott Laboratories (Symbol: ABT) displayed significant trading volume, with a total of 35,413 contracts exchanged. This figure equates to about 3.5 million underlying shares and represents approximately 48.1% of ABT’s average daily trading volume of 7.4 million shares over the past month. Notably, the $135 strike call option expiring on April 11, 2025, saw an impressive 26,686 contracts traded, translating to around 2.7 million underlying shares of ABT. The chart below illustrates ABT’s trading history over the past twelve months, marking the $135 strike in orange:
Celsius Holdings Inc (Symbol: CELH) recorded options trading volume of 43,941 contracts today, representing around 4.4 million underlying shares. This accounts for a considerable 47.4% of CELH’s average daily trading volume of 9.3 million shares over the last month. The $37 strike call option expiring on April 11, 2025, was particularly active, with 5,194 contracts trading, corresponding to about 519,400 underlying shares. The chart below depicts CELH’s trading history, highlighting the $37 strike:
Additionally, Newmont Corp (Symbol: NEM) reported options trading volume of 54,933 contracts today, which equals roughly 5.5 million underlying shares. This volume is significant at 44.7% of NEM’s average daily trading volume of 12.3 million shares over the past month. The $60 strike call option expiring on January 16, 2026, stood out with 10,118 contracts traded, representing approximately 1.0 million underlying shares of NEM. The following chart outlines NEM’s trading history over the last twelve months, with the $60 strike marked in orange:
For information on available expirations for options on ABT, CELH, or NEM, visit StockOptionsChannel.com.
Today’s Most Active Call & Put Options of the S&P 500 »
also see:
- Oversold Metals Stocks
- COMS Videos
- SONG YTD Return
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.